Luteolin stimulates the NGF-induced neurite outgrowth in cultured PC12 cells through binding with NGF and potentiating its receptor signaling

Luteolin, a flavonoid in fruits and vegetables, has neurotrophic functions without a well-characterized mechanism. Here, we hypothesize a direct interaction of luteolin with nerve growth factor (NGF); as such, the functionality of the NGF could be potentiated. The direct binding of luteolin with NGF was validated by ultra-filtration, Biacore, and docking analyses. In cultured PC12 cells, application of luteolin in combination with a low dose of NGF potentiated the NGF-induced differentiation of neurons by an increase of the differentiated cell number to 25.4 +/- 4.8% (p < 0.01), as well as the increased expression of neurofilaments by 119 +/- 32.1% (p < 0.05), 191 +/- 12.6% (p < 0.01), and 110 +/- 23.4% (p < 0.05) for NF68, NF160 and NF200, respectively. The co-treatment induced the phosphorylations of tropomyosin receptor kinase A (TrkA), extracellular signal-regulated kinase 1/2 (ERK1/2), protein kinase B (Akt), phospholipase C-gamma 1 (PLC gamma 1), and cAMP response element-binding protein (CREB) by 2 to 3 fold: these induced phosphorylations were mimicking that of a high dose of NGF. Moreover, the application of the TrkA inhibitor, K252a, blocked the luteolin-mediated induction of neurofilament expression and neurite outgrowth in cultured PC12 cells, suggesting the target specificity. The result supports the development of luteolin as a therapeutic, or preventive, agent for NGF insufficiency-associated neurodegenerative diseases.

Automated summary

The study demonstrated that luteolin can directly interact with nerve growth factor (NGF), enhancing NGF-induced neuronal differentiation and neurofilament expression in cultured PC12 cells. The co-treatment also activated key signaling pathways involved in neuronal growth, mimicking the effects of a high dose of NGF. These findings support the potential development of luteolin as a therapeutic agent for NGF insufficiency-related neurodegenerative diseases.